Lv3
240 积分 2024-03-14 加入
Pharmacological Targets for Pulmonary Vascular Disease: Vasodilation versus Anti-Remodelling
3个月前
已完结
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension
3个月前
已完结
Treatment of pulmonary arterial hypertension: recent progress and a look to the future
3个月前
已完结
Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension
8个月前
已完结
Exploration of the molecular mechanism of tea polyphenols against pulmonary hypertension by integrative approach of network pharmacology, molecular docking, and experimental verification
8个月前
已完结
Pulmonary Arterial Hypertension
8个月前
已完结
Pulmonary Hypertension
8个月前
已完结
Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension
10个月前
已完结
Luteoloside induces G0/G1 arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines
1年前
已完结
The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11
1年前
已完结
皖公网安备34019202002308
